You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Boehringer Ingelheim
Mallinckrodt
McKinsey
McKesson

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

Methocarbamol - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for methocarbamol and what is the scope of freedom to operate?

Methocarbamol is the generic ingredient in five branded drugs marketed by Dr Reddys, Marsam Pharms Llc, Am Regent, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Gland Pharma Ltd, Monterey Pharms Llc, Mylan Institutional, Navinta Llc, Sagent Pharms Inc, Slate, Somerset Theraps Llc, Hikma, Ferndale Labs, Forest Labs, Able, Am Therap, Ani Pharms Inc, Ascot, Austarpharma Llc, Beximco Pharms Usa, Clonmel Hlthcare, Dbl Pharms, Fosun Pharma, Granules India Ltd, Heather, Hetero Labs Ltd Iii, Hikma Intl Pharms, Impax Labs, Inwood Labs, Ivax Sub Teva Pharms, Kv Pharm, Lannett Co Inc, Mylan, Nylos, Oxford Pharms, Pioneer Pharms, Prinston Inc, Puracap Pharm, Purepac Pharm, Roxane, Sandoz, Solvay, Sun Pharm Industries, Superpharm, Tablicaps, Upsher Smith, Watson Labs, and Auxilium Pharms Llc, and is included in seventy-one NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for methocarbamol. Fifty-one suppliers are listed for this compound.

Drug Prices for methocarbamol

See drug prices for methocarbamol

Drug Sales Revenue Trends for methocarbamol

See drug sales revenues for methocarbamol

Recent Clinical Trials for methocarbamol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tanta UniversityPhase 3
Boehringer IngelheimPhase 3
Montefiore Medical CenterPhase 4

See all methocarbamol clinical trials

Pharmacology for methocarbamol
Medical Subject Heading (MeSH) Categories for methocarbamol

US Patents and Regulatory Information for methocarbamol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Puracap Pharm METHOCARBAMOL methocarbamol TABLET;ORAL 084471-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa METHOCARBAMOL methocarbamol SOLUTION;IM-IV 209331-001 Apr 17, 2018 AP RX No No   Start Trial   Start Trial   Start Trial
Kv Pharm METHOCARBAMOL methocarbamol TABLET;ORAL 085658-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Roxane METHOCARBAMOL methocarbamol TABLET;ORAL 088647-001 Feb 29, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Boehringer Ingelheim
Mallinckrodt
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.